Genesis Healthcare (GENN) Stock Price
Genesis Healthcare Price
Revenue at Genesis Healthcare has contracted by 7.0% per year over the past 5 years to 3.91 B USD. Genesis Healthcare's net margin stands at -1.5%, broadly stable from -1.1% several years earlier. Of 6 analysts, 0 rate the stock a buy — an overall Sell consensus.
Genesis Healthcare stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Genesis Healthcare over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Genesis Healthcare stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Genesis Healthcare's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Genesis Healthcare Price |
|---|
Genesis Healthcare Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Genesis Healthcare Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEB USD |
|---|
| REVENUE GROWTH% |
| EBITM USD |
| EBIT MARGIN% |
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| SHARESM |
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021e | 2022e |
|---|---|---|---|---|---|---|---|
| 5.62 | 5.73 | 5.37 | 4.98 | 4.57 | 3.91 | 3.53 | 3.09 |
| – | 2.01 | -6.26 | -7.39 | -8.26 | -14.44 | -9.60 | -12.52 |
| 276.00 | 446.00 | 83.00 | 222.00 | 224.00 | -67.00 | 144.00 | 114.00 |
| 4.91 | 7.78 | 1.54 | 4.46 | 4.91 | -1.72 | 4.08 | 3.69 |
| -426.00 | -64.00 | -578.00 | -235.00 | 14.00 | -58.00 | 42.00 | 44.00 |
| – | -84.98 | 803.13 | -59.34 | -105.96 | -514.29 | -172.41 | 4.76 |
| 85.76 | 89.87 | 94.22 | 101.01 | 165.31 | 111.85 | 111.85 | 111.85 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Genesis Healthcare generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Genesis Healthcare retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Genesis Healthcare's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Genesis Healthcare has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Genesis Healthcare's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Genesis Healthcare stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Genesis Healthcare Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Genesis Healthcare business model & stock analysis
Genesis Healthcare SWOT Analysis
Strengths
1. Established Market Presence: Genesis Healthcare Inc has a strong presence in the healthcare industry, supported by its numerous facilities and services.
2. Extensive Range of Services: The company offers a wide range of healthcare services including physical rehabilitation, long-term care, assisted living, and more.
3. Experienced Workforce: Genesis Healthcare Inc boasts a highly skilled and experienced workforce consisting of medical professionals, caregivers, and support staff.
Weaknesses
1. Financial Challenges: The company has faced challenges related to its financial performance, including potential debt burdens and limited liquidity.
2. Regulatory Compliance: Genesis Healthcare Inc operates in a heavily regulated industry, necessitating compliance with various healthcare regulations and potential risks of non-compliance.
3. Dependent on Government Funding: The company relies on government reimbursement programs such as Medicare and Medicaid, making it susceptible to changes in government policies and funding.
Opportunities
1. Aging Population: The increasing aging population presents an opportunity for Genesis Healthcare Inc to expand its services and cater to the growing demand for senior care.
2. Technological Advancements: Embracing technological advancements in healthcare can help the company enhance patient care, improve operational efficiency, and stay ahead of competitors.
3. Strategic Partnerships: Collaborating with pharmaceutical companies, insurance providers, or other healthcare organizations can lead to synergistic partnerships and expanded service offerings.
Threats
1. Competitive Landscape: Genesis Healthcare Inc operates in a highly competitive industry, facing competition from established healthcare providers as well as new entrants.
2. Changing Reimbursement Policies: Alterations in government reimbursement policies, insurance coverage, or medical reimbursement structures can impact the company's financial stability.
3. Legal and Regulatory Risks: The healthcare sector is subject to potential legal and regulatory challenges, such as malpractice lawsuits, privacy breaches, and changing compliance requirements.
Genesis Healthcare Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Genesis Healthcare historical P/E ratio, EBIT multiple, and P/S ratio
Genesis Healthcare annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Genesis Healthcare shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Current Genesis Healthcare forecasts and price targets in August 2026
Analyst Price Targets 2026Genesis Healthcare Earnings Estimates & Surprises
| Date | EPS estimate | EPS Actual | Revenue Estimate | Price reaction | Quarterly report |
|---|---|---|---|---|---|
| 8/10/2020 | -0.03USD | - | 1.13 BUSD | - | 2020 Q2 |
EESG©
Eulerpool ESG Scorecard© for the Genesis Healthcare stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Genesis Healthcare shareholder structure
| % | Name |
|---|---|
0.00019% | |
0.00000% | |
0.00000% |
Genesis Healthcare Executives and Management Board
11 members · avg. age 62 · 9 % women
Mr. Paul Bach (62)
Chief Operating Officer · since 2017
824,750.00 USD
Management
Mr. Thomas DiVittorio (53)
Chief Financial Officer, Executive Vice President
Dr. JoAnne Reifsnyder (62)
Executive Vice President - Clinical Operations, Chief Nursing Officer
Mr. Michael Sherman
Senior Vice President, General Counsel, Assistant Treasurer, Secretary · since 2016
Mr. Harry Wilson (49)
Chief Executive Officer, Director · since 2021
Dr. Richard Feifer (57)
Executive Vice President
Board of Directors
Mr. Robert Fish (70)
Director · since 2013
Mr. John Randazzo (66)
Director
Mr. Arnold Whitman
Director
Mr. Robert Hartman (64)
Director
Mr. David Harrington (76)
Executive Chairman of the Board · since 2021
Genesis Healthcare Supply Chain
Genesis Healthcare Supply Chain
Correlation: how closely stock prices move together
| # | Name | Trend | |||
|---|---|---|---|---|---|
| 1 | -0.08 | 0.82 | 0.43 | ||
| 2 | -0.52 | 0.22 | 0.39 | ||
| 3 | 0.13 | 0.77 | 0.34 |
Frequently asked questions about Genesis Healthcare
Genesis Healthcare Inc. operates as a leading provider of healthcare services in the United States. The company offers a comprehensive continuum of care to seniors, including skilled nursing, assisted living, rehabilitation therapy, and independent living. Genesis Healthcare focuses on delivering high-quality and personalized services to improve the health and well-being of its patients. Through its vast network of healthcare facilities, the company strives to provide access to affordable and reliable healthcare solutions. With a strong commitment to patient-centered care and a dedicated team of healthcare professionals, Genesis Healthcare Inc. aims to enhance the quality of life for seniors by promoting their overall physical, emotional, and social wellness.
Genesis Healthcare Inc is primarily active in the healthcare industry.
The main competitors of Genesis Healthcare Inc in the market are Brookdale Senior Living Inc, Ensign Group Inc, and Sabra Health Care REIT Inc.
Genesis Healthcare Inc is a renowned company in the healthcare industry. Established in 2003, Genesis Healthcare Inc specializes in providing high-quality senior care services across the United States. With a vast network of skilled nursing centers, assisted living, and rehabilitation facilities, Genesis Healthcare Inc stands as a trusted name in the sector. The company is committed to enhancing the lives of seniors and individuals with special needs through personalized care and cutting-edge medical practices. With its extensive experience, Genesis Healthcare Inc continues to excel in delivering exceptional care and improving the well-being of its patients.
Genesis Healthcare Inc has achieved several significant milestones throughout its history. Since its establishment, the company has become one of the leading providers of post-acute care services in the United States. Genesis Healthcare Inc has successfully expanded its operations, acquiring various skilled nursing facilities and rehabilitation therapy businesses. Furthermore, the company takes pride in its commitment to delivering high-quality healthcare services to patients in need. With a strong focus on patient-centered care and innovation, Genesis Healthcare Inc continues to strive towards enhancing the health and well-being of individuals across the nation.
Genesis Healthcare Inc is primarily present in the United States.
Genesis Healthcare Inc represents a strong set of values and corporate philosophy that sets them apart in the industry. The company strives to provide high-quality healthcare services that prioritize patient well-being and comfort. With a focus on integrity, compassion, and innovation, Genesis Healthcare Inc aims to deliver personalized care and exceptional outcomes for their patients. By incorporating the latest advancements in technology and continuously improving their services, they are committed to creating a nurturing and inclusive environment. Genesis Healthcare Inc's dedication to excellence has made them a trusted name in the healthcare industry.
6 analysts currently rate the Genesis Healthcare stock: 0 recommend buying, 2 holding and 4 selling.
Genesis Healthcare Inc is a leading provider of care and health services in the USA. The company operates a diverse portfolio of facilities, including skilled nursing facilities, assisted living, rehabilitation centers, and outpatient healthcare facilities. Genesis Healthcare is committed to providing high-quality care and patient-centered care based on individualized attention. The business operations of Genesis Healthcare are divided into two main segments: skilled nursing facilities and rehabilitation services. The skilled nursing facilities segment is the largest and encompasses over 325 facilities in 24 states, as well as several community and home care programs and hospice services. The rehabilitation services segment offers acute and post-acute services and is provided in over 70 facilities in 16 states. In addition to providing care, Genesis Healthcare facilities offer various medical services, including physical, speech, and occupational therapy, as well as specialized care for patients with chronic diseases such as Alzheimer's and dementia. Furthermore, Genesis Healthcare's services also include the treatment of chronic pain and post-surgical care. The company strives to provide comprehensive care to its customers, covering all aspects of health and well-being. For this reason, Genesis Healthcare offers a variety of programs and services to ensure that patients can enjoy life to the fullest. These include nutritional counseling, occupational therapy, recreational activities, and psychological counseling. Genesis Healthcare's services are tailored to the needs of patients of all age groups, including children, adults, and seniors. Moreover, Genesis Healthcare also offers advanced technologies and innovative practices to maximize the quality of care and patient-centered care. The company has its own research and development department, which focuses on the development of new technologies and treatment methods. Overall, Genesis Healthcare focuses on creating value for its customers through comprehensive and individualized care tailored to their needs. By providing high-quality care and health services and promoting a positive and supportive environment, Genesis Healthcare has built a strong market position and established itself as one of the leading providers in the industry.
The revenue cannot currently be calculated for Genesis Healthcare.
The profit cannot currently be calculated for Genesis Healthcare.
The P/E ratio cannot be calculated for Genesis Healthcare at the moment.
The P/S cannot be calculated for Genesis Healthcare currently.
The Eulerpool Quality Score for Genesis Healthcare is 1/10.
The ISIN of Genesis Healthcare is US37185X1063. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Genesis Healthcare is A14NEW. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Genesis Healthcare is GENN. The ticker symbol is used to trade Genesis Healthcare shares on the stock exchange.
Genesis Healthcare is assigned to the 'Health' sector.
The dividends of Genesis Healthcare are distributed in USD.
Genesis Healthcare stock
Genesis Healthcare Peer Group
Genesis Healthcare Ticker
Genesis Healthcare FIGI
All fundamentals and in-depth analysis of Genesis Healthcare
Our stock analysis for Genesis Healthcare stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Genesis Healthcare. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.